Page last updated: 2024-10-25

deferiprone and Liver Diseases

deferiprone has been researched along with Liver Diseases in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Liver Diseases: Pathological processes of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tauchenová, L1
Křížová, B1
Kubánek, M1
Fraňková, S1
Melenovský, V1
Tintěra, J1
Kautznerová, D1
Malušková, J1
Jirsa, M1
Kautzner, J1
Sandmeier, P1
Clauss, M1
Donati, OF1
Chiers, K1
Kienzle, E1
Hatt, JM1

Other Studies

2 other studies available for deferiprone and Liver Diseases

ArticleYear
Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone.
    The Canadian journal of cardiology, 2016, Volume: 32, Issue:12

    Topics: Cardiomyopathies; Deferiprone; Deferoxamine; Ferritins; Heart Failure; Hemochromatosis; Hemochromato

2016
Use of deferiprone for the treatment of hepatic iron storage disease in three hornbills.
    Journal of the American Veterinary Medical Association, 2012, Jan-01, Volume: 240, Issue:1

    Topics: Animals; Bird Diseases; Birds; Deferiprone; Female; Iron Chelating Agents; Iron Overload; Liver Dise

2012